Tocilizumab may improve survival in sickest COVID-19 patients, scientists say
In the observational study, the researchers noted that 210 patients received tocilizumab, and the other 420 did not. Tocilizumab, a drug normally used in rheumatoid arthritis and cancer treatments, may improve hospital survival in critically-ill COVID-19 patients admitted to the intensive care unit (ICU), according to an observational study of more than 600 people infected … Read more